| 1 |
31292311 | The differential influence of glimepiride and glibenclamide on insulin resistance and adiponectin levels in patients with type 2 diabetes. | 2019 Oct 28 |
1 |
| 2 |
27705028 | Type 2 diabetes and metabolic syndrome - adipokine levels and effect of drugs. | 2017 Jan |
1 |
| 3 |
26376464 | Liraglutide treatment causes upregulation of adiponectin and downregulation of resistin in Chinese type 2 diabetes. | 2015 Nov |
1 |
| 4 |
24650537 | Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes. | 2014 Mar 20 |
1 |
| 5 |
24957699 | Adiponectin: a manifold therapeutic target for metabolic syndrome, diabetes, and coronary disease? | 2014 Jun 23 |
1 |
| 6 |
25092992 | Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin. | 2014 |
1 |
| 7 |
19154945 | Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus. | 2009 Feb |
4 |
| 8 |
16538000 | Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis. | 2006 Feb |
1 |
| 9 |
12547850 | Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. | 2003 Feb |
3 |
| 10 |
12832345 | Effect of glimepiride on serum adiponectin level in subjects with type 2 diabetes. | 2003 Jul |
1 |